Lurasidone HCl: A Phase 3 Study of Patients With Acute Schizophrenia
Clinical trial NCT00549718 · COMPLETED
Trial details
- NCT number
- NCT00549718
- Sponsor
- Sumitomo Pharma America, Inc.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2007-10-01
- Primary completion
- 2010-10-01
- Enrollment
- 489
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.